CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 12.05
-0.56 (-4.44%)
Sep 10, 2025, 11:59 AM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 18.38 billion as of September 9, 2025. Its market cap has increased by 991.71% in one year.
Market Cap
18.38B
Enterprise Value
18.05B
Revenue
221.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.05
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has increased from 12.65B to 18.38B, an increase of 45.23%. That is a compound annual growth rate of 5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 18.38B | 525.98% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | 11.60B | 11.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 224.72B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 159.35B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |